Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGEN | VRNA | LEGN | ||
| Company | Repligen Corp | Verona Pharma Plc ADR | Legend Biotech Corp ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 128.28 | 92.00 | 36.86 | ||
| High | 130.95 | 93.47 | 37.19 | ||
| Low | 127.00 | 91.16 | 36.32 | ||
| Last | 127.52 | 92.20 | 36.83 | ||
| Change | -3.78 | -0.30 | -1.08 | ||
| % Change | -2.88% | -0.32% | -2.85% | ||
| Volume | 507,100 | 754,400 | 1,554,700 | ||
| 20-Day Average Volume | 725,865 | 1,426,505 | 2,139,935 | ||
| Previous Close | 131.30 | 92.50 | 37.91 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 125.15 | 80.88 | 31.33 | ||
| 20-Day Raw Stochastic | 61.41% | 93.77% | 78.95% | ||
| 20-Day Relative Strength | 48.63% | 73.92% | 61.09% | ||
| Weighted Alpha | -6.37 | +437.52 | -14.39 | ||
| Today's Opinion | 80% Sell | 100% Buy | 24% Sell | ||
| Previous Opinion | 64% Sell | 100% Buy | 24% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.61% since 06/06/25 | +9.32% since 06/06/25 | +5.23% since 06/06/25 | ||
| Low | 127.00 on 06/13/25 | 82.88 on 06/09/25 | 34.26 on 06/09/25 | ||
| High | 135.30 on 06/11/25 | 93.74 on 06/12/25 | 39.36 on 06/12/25 | ||
| 1-Month | |||||
| %Chg | -3.06% since 05/13/25 | +36.45% since 05/13/25 | +18.50% since 05/13/25 | ||
| Low | 115.14 on 06/03/25 | 66.64 on 05/15/25 | 27.34 on 05/16/25 | ||
| High | 135.30 on 06/11/25 | 93.74 on 06/12/25 | 39.36 on 06/12/25 | ||
| 3-Month | |||||
| %Chg | -10.47% since 03/13/25 | +41.06% since 03/13/25 | -3.21% since 03/13/25 | ||
| Low | 102.96 on 04/07/25 | 47.20 on 04/07/25 | 27.34 on 05/16/25 | ||
| High | 153.89 on 03/17/25 | 93.74 on 06/12/25 | 39.36 on 06/12/25 | ||
| 6-Month | |||||
| %Chg | -18.47% since 12/13/24 | +122.60% since 12/13/24 | +4.87% since 12/13/24 | ||
| Low | 102.96 on 04/07/25 | 39.67 on 12/18/24 | 27.34 on 05/16/25 | ||
| High | 182.52 on 01/28/25 | 93.74 on 06/12/25 | 40.00 on 02/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,164,455 | 7,475,576 | 6,767,992 | ||
| Shares Outstanding, K | 56,183 | 81,080 | 183,763 | ||
| Annual Sales | 634,440,000 | 42,280,000 | 627,240,000 | ||
| Annual Net Income | -25,510,000 | -173,420,000 | -177,030,000 | ||
| Last Quarter Sales | 169,170,000 | 76,260,000 | 195,050,000 | ||
| Last Quarter Net Income | 5,830,000 | -16,320,000 | -100,920,000 | ||
| 60-Month Beta | 1.10 | 0.21 | 0.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.39 on 04/29/25 | 0.27 on 04/29/25 | -0.07 on 05/13/25 | ||
| Latest Earnings Date | 07/29/25 | 04/29/25 | 08/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 82.58 | 0.00 | 0.00 | ||